Duration of the effects of intravenous alendronate in postmenopausal women and in patients with primary hyperparathyroidism and Paget's disease of bone
- 1 May 1994
- journal article
- Published by Elsevier in Bone and Mineral
- Vol. 25 (2) , 75-82
- https://doi.org/10.1016/s0169-6009(08)80249-8
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- The effect of short term treatment with alendronate on vertebral density and biochemical markers of bone remodeling in early postmenopausal womenJournal of Clinical Endocrinology & Metabolism, 1993
- Effects of five daily 1 h infusions of alendronate in paget's disease of boneJournal of Bone and Mineral Research, 1992
- Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure.Journal of Clinical Investigation, 1991
- BisphosphonatesDrugs, 1991
- Treatment of paget's disease of bone with aminohydroxybutylidene bisphosphonateJournal of Bone and Mineral Research, 1990
- TREATMENT OF PAGET'S DISEASE OF BONEClinical Endocrinology, 1990
- A single infusion of the bisphosphonate AHPrBP (APD) as treatment of Paget's disease of boneThe American Journal of Medicine, 1988
- Efficacious Management with Aminobisphosphonate (APD) in Paget??s Disease of BoneClinical Orthopaedics and Related Research, 1987
- Treatment of Paget's disease of bone with intravenous 4-amino-1-hydroxybutylidene-1,1-bisphosphonateCalcified Tissue International, 1986
- Regulation of calcium absorption by 1,25,dihydroxy-vitamin D—Studies of the effects of a bisphosphonate treatmentCalcified Tissue International, 1982